CD5L expression was significantly negatively correlated with the LN_IC50s of Mitoxantrone, OTX015, and I-BRD9 while positively correlated that of Fulvestrant (Table 2), indicating its positive/negative correlations with the sensitivity of HCC cell lines to the four drugs. The gene discussed is CD5L; the disease is hepatocellular carcinoma.